Home
About Symray
Company Profile
Milestones
Management Team
Technology Platforms
Antibody Discovery Platform
Antibody Characterization Platform
Drug Validation Platform
Pipeline
Lead & Candidate Antibody Drugs
Hit Antibodies
External Collaboration
Collaboration Models
Partners
News
Join Us
Corporate Culture
Careers
Contact Us
中文
Home
About Symray
Company Profile
Milestones
Management Team
Technology Platforms
Pipeline
External Collaboration
Collaboration Models
Partners
News
Join Us
Corporate Culture
Careers
Contact Us
Pipeline
Home
Pipeline
Hit Antibodies
Lead & Candidate Antibody Drugs
Hit Antibodies
LILRB4/CD85k
Published on: 2025/12/18
Previous: LGR4
Next: LILRB1/CD85J
Back to list